Arsenic trioxide induces the apoptosis of human breast cancer MCF-7 cells through activation of caspase-3 and inhibition of HERG channels

Wang,Ying; Zhang,Yong; Yang,Lei; Cai,Benzhi; Li,Jianping; Zhou,You; Yin,Li; Yang,Lili; Yang,Baofeng; Lu,Yanjie

doi:10.3892/etm.2011.224

Arsenic trioxide induces the apoptosis of human breast cancer MCF-7 cells through activation of caspase-3 and inhibition of HERG channels

Authors:
- Ying Wang
- Yong Zhang
- Lei Yang
- Benzhi Cai
- Jianping Li
- You Zhou
- Li Yin
- Lili Yang
- Baofeng Yang
- Yanjie Lu
View Affiliations

Affiliations: Department of Pharmacology, State-Province Key Laboratories of Biomedicine and Pharmaceutics, Heilongjiang 150081, P.R. China
Published online on: March 8, 2011 https://doi.org/10.3892/etm.2011.224
Pages: 481-486

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Arsenic trioxide (As2O3) has been widely used to treat patients with acute promyelocytic leukemia and has also been shown to exhibit therapeutic effects on various types of solid tumors, including gastric cancer and lung carcinoma. Breast cancer is a type of solid tumor whose incidence has been increasing for many years. The present study was designed to investigate the effects of As2O3 on the human breast cancer cell line MCF-7, and to explore its potential mechanisms. The MTT assay demonstrated that As2O3 decreased the cellular viability of MCF-7 cells in a concentration-dependent manner. Morphological observation, the TUNEL assay and flow cytometric analysis revealed that apoptosis was involved in the process. An assay for caspase-3 activity suggested that the apoptosis was mediated through caspase-3 activation. Further investigation indicated that protein levels of the human ether‑a-go-go-related gene (HERG) were markedly downregulated by As2O3. Taken together, the results indicate that arsenic trioxide induces the apoptosis of human breast cancer MCF-7 cells at least in part through the activation of caspase-3 and the decrease in HERG expression.

View Figures

View References

1.	Sledge GW Jr: Breast cancer as a world challenge. Clin Breast Cancer. 5:112004. View Article : Google Scholar : PubMed/NCBI
2.	Bange J, Zwick E and Ullrich A: Molecular targets for breast cancer therapy and prevention. Nat Med. 7:548–552. 2001. View Article : Google Scholar : PubMed/NCBI
3.	Vernhet L, Allain N, Le Vee M, Morel F, Guillouzo A and Fardel O: Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons. J Pharmacol Exp Ther. 304:145–155. 2003. View Article : Google Scholar
4.	Cyranoski D: Arsenic patent keeps drug for rare cancer out of reach of many. Nat Med. 13:10052007. View Article : Google Scholar : PubMed/NCBI
5.	Sun HD, Ma L, Hu XC and Zhang TD: Ai-Lin I treated 32 cases of acute promyelocytic leukemia. Chin J Integr Chin West Med. 12:170–171. 1992.
6.	Woo SH, Park IC, Park MJ, et al: Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. Int J Oncol. 21:57–63. 2002.
7.	Zhang TC, Cao EH, Li JF, Ma W and Qin JF: Induction of apoptosis and inhibition of human gastric cancer MG803 cell growth by arsenic trioxide. Eur J Cancer. 35:1258–1263. 1999. View Article : Google Scholar : PubMed/NCBI
8.	Shen ZY, Shen J, Cai WJ, Hong C and Zheng MH: The alteration of mitochondria is an early event of arsenic trioxide-induced apoptosis in esophageal carcinoma cells. Int J Mol Med. 5:155–158. 2000.PubMed/NCBI
9.	Akao Y, Nakagawa Y and Akiyama K: Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro. FEBS Lett. 455:59–62. 1999. View Article : Google Scholar : PubMed/NCBI
10.	Uslu R, Sanli UA, Sezgin C, et al: Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin Cancer Res. 6:4957–4964. 2000.PubMed/NCBI
11.	Chow SK, Chan JY and Fung KP: Inhibition of cell proliferation and the action mechanisms of arsenic trioxide As₂O₃ on human breast cancer cells. J Cell Biochem. 93:173–187. 2004. View Article : Google Scholar : PubMed/NCBI
12.	Ye J, Li A, Liu Q, Wang X and Zhou J: Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells. Clin Exp Pharmacol Physiol. 32:1042–1048. 2005. View Article : Google Scholar
13.	Wang H, Zhang Y, Cao L, et al: HERG K⁺ channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res. 62:4843–4848. 2002.PubMed/NCBI
14.	Sun HL, Chu WF, Dong DL, et al: Choline-modulated arsenic trioxide-induced prolongation of cardiac repolarization in Guinea pig. Basic Clin Pharmacol Toxicol. 98:381–388. 2006. View Article : Google Scholar : PubMed/NCBI
15.	Ficker E, Kuryshev YA, Dennis AT, et al: Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol. 66:33–44. 2004. View Article : Google Scholar : PubMed/NCBI
16.	Vandenberg JI, Walker BD and Campbell TJ: HERG K⁺ channels: friend and foe. Trends Pharmacol Sci. 22:240–246. 2001.
17.	Bianchi L, Wible B, Arcangeli A, et al: herg encodes a K⁺ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res. 58:815–822. 1998.
18.	Cherubini A, Taddei GL, Crociani O, et al: HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium. Br J Cancer. 83:1722–1729. 2000. View Article : Google Scholar
19.	Meyer R and Heinemann SH: Characterization of an eag-like potassium channel in human neuroblastoma cells. J Physiol. 508:49–56. 1998. View Article : Google Scholar : PubMed/NCBI
20.	Shao XD, Wu KC, Hao ZM, Hong L, Zhang J and Fan DM: The potent inhibitory effects of cisapride, a specific blocker for human ether-a-go-go-related gene (HERG) channel, on gastric cancer cells. Cancer Biol Ther. 4:295–301. 2005. View Article : Google Scholar
21.	Wang L, Feng ZP, Kondo CS, Sheldon RS and Duff HJ: Developmental changes in the delayed rectifier K⁺channels in mouse heart. Circ Res. 79:79–85. 1996. View Article : Google Scholar : PubMed/NCBI
22.	Wang L and Duff HJ: Identification and characteristics of delayed rectifier K⁺ current in fetal mouse ventricular myocytes. Am J Physiol. 270:H2088–H2093. 1996.PubMed/NCBI
23.	Liu P and Han ZC: Treatment of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide: review of clinical and basic studies. Int J Hematol. 78:32–39. 2003. View Article : Google Scholar : PubMed/NCBI
24.	Han H, Long H, Wang H, Wang J, Zhang Y and Wang Z: Progressive apoptotic cell death triggered by transient oxidative insult in H9c2 rat ventricular cells: a novel pattern of apoptosis and the mechanisms. Am J Physiol Heart Circ Physiol. 286:H2169–H2182. 2004. View Article : Google Scholar
25.	Roy S: Caspase at the heart of the apoptotic cell death pathway. Chem Res Toxicol. 13:961–962. 2000. View Article : Google Scholar : PubMed/NCBI
26.	Li X, Ding X and Adrian TE: Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells. Cancer Invest. 22:389–400. 2004. View Article : Google Scholar
27.	Crociani O, Guasti L, Balzi M, et al: Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem. 278:2947–2955. 2003. View Article : Google Scholar : PubMed/NCBI
28.	Guasti L, Crociani O, Redaelli E, et al: Identification of a post-translational mechanism for the regulation of hERG1 K⁺ channel expression and hERG1 current density in tumor cells. Mol Cell Biol. 28:5043–5060. 2008. View Article : Google Scholar : PubMed/NCBI
29.	Arcangeli A: Expression and role of hERG channels in cancer cells. Novartis Found Symp. 266:225–232. 2005. View Article : Google Scholar : PubMed/NCBI
30.	Li H, Liu L, Guo L, et al: HERG K⁺ channel expression in CD34⁺/CD38⁻/CD123 (high) cells and primary leukemia cells and analysis of its regulation in leukemia cells. Int J Hematol. 87:387–392. 2008.
31.	Afrasiabi E, Hietamäki M, Viitanen T, Sukumaran P, Bergelin N and Törnquist K: Expression and significance of HERG (KCNH2) potassium channels in the regulation of MDA-MB-435S melanoma cell proliferation and migration. Cell Signal. 22:57–64. 2010. View Article : Google Scholar : PubMed/NCBI
32.	Zhao J, Wei XL, Jia YS and Zheng JQ: Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivo. Eur J Pharmacol. 579:50–57. 2008. View Article : Google Scholar : PubMed/NCBI
33.	Cherubini A, Hofmann G, Pillozzi S, Guasti L, Crociani O, Cilia E, et al: Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling. Mol Biol Cell. 16:2972–2983. 2005. View Article : Google Scholar : PubMed/NCBI
34.	Bauer CK, Wulfsen I, Schafer R, Glassmeier G, Wimmers S and Flitsch J: HERG K(+) currents in human prolactin-secreting adenoma cells. Pflugers Arch. 445:589–600. 2003.
35.	Gullo F, Ales E, Rosati B, et al: ERG K⁺ channel blockade enhances firing and epinephrine secretion in rat chromaffin cells: the missing link to LQT2-related sudden death? FASEB J. 17:330–332. 2003.PubMed/NCBI
36.	Rosati B, Marchetti P, Crociani O, et al: Glucose- and arginine-induced insulin secretion by human pancreatic beta-cells: the role of HERG K(+) channels in firing and release. FASEB J. 14:2601–2610. 2000.PubMed/NCBI
37.	Shao XD, Wu KC, Guo XZ, Xie MJ, Zhang J and Fan DM: Expression and significance of HERG protein in gastric cancer. Cancer Biol Ther. 7:45–50. 2008. View Article : Google Scholar : PubMed/NCBI
38.	Lastraioli E, Guasti L, Crociani O, et al: herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res. 64:606–611. 2004. View Article : Google Scholar : PubMed/NCBI
39.	Masi A, Becchetti A, Restano-Cassulini R, et al: hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines. Br J Cancer. 93:781–792. 2005. View Article : Google Scholar : PubMed/NCBI